Bengaluru (Karnataka) [India], October 17: MedGenome, a leading global genomics-driven diagnostics and research services company, proudly marks a decade of transformative contributions to healthcare. Founded in 2013, MedGenome has been at the forefront of integrating genomics into clinica
New Delhi [India], September 24: Cardiovascular diseases (CVD) remain a major health concern in India, accounting for 28.1% of deaths, as per a study published on Lancet Global Health. A troubling trend is the increasing number of young adults affected by heart disease, with 1 in 5 heart att
In keeping with the vision of 'One world, one health,' PM Modi announced the dedication of a grant of US USD 7.5 million to cancer testing, screening and diagnostics in the Indo-Pacific region.
Foster City (California) [US]/ Bangalore (Karnataka) [India], September 11: MedGenome, a leading global genomics-driven diagnostics and research services company, announced the appointment of Dr. Amit Kakar as Chairman of its Board, effective immediately.
Chennai (Tamil Nadu) [India], August 9: LifeCell, India's pioneering stem cell bank and a leader in diagnostics, genetic testing, and pre-conception care, is poised to disrupt the world of mother-baby skincare with the launch of AreoVeda. With this, the brand has unveiled a product range,
A global leader in medical diagnostics, Atellica announced the pioneering implementation of the new Atellica CI, independent integrated diagnostic testing analyzer at Imaging centre & Labs, to make patient care more predictable and agile in today's evolving healthcare landscape.
Baruipur (West Bengal) [India], August 1: AccuHealth Diagnostics is excited to announce the launch of its advanced CT Scan facility at the Baruipur branch. This new addition brings high-quality, accessible healthcare to the residents of Baruipur and surrounding areas, ensuring state-of-the-a
"This budget is status quo for health concerns, with only two silver linings: customs duty exemptions on diagnostics and cancer drugs. The economy has moved from USD 3.4 trillion to USD 4 trillion," said Dr Asokan.
Most rare diseases are caused by genetics. A molecular genetic diagnosis can be made more quickly and readily by identifying the underlying genetic change, for instance by exome sequencing (ES). The analysis of every region of our DNA that codes for a protein is known as ES.
Seoul [South Korea], July 11: Medit, a leading provider of dental 3D scanners and digital dentistry solutions, has appointed Han Ryu as its new CEO. Han brings with him over three decades of senior management experience in global medical device and healthcare companies, including prominent r
Mumbai (Maharashtra) [India], June 25: SNG & Partners, a full-service law firm with offices in India and overseas has announced a strategic alliance with Snowkap, a Singapore-based ESG firm with a presence in the Middle East and India, to blend legal acumen with ESG excellence and togeth
New Delhi [India], June 24: Human Diagnostics GmbH, Wiesbaden, Germany, a global player in the in vitro diagnostics industry, offering a broad portfolio of high quality made in Germany products to over 160 countries for over 50 years, and Medsource Ozone Biomedicals, one of the largest India